Financial results - BIOINVENT MEDICAL SRL

Financial Summary - Bioinvent Medical Srl
Unique identification code: 37799854
Registration number: J2017001167021
Nace: 4690
Sales - Ron
20.776
Net Profit - Ron
-2.038
Employees
1
Open Account
Company Bioinvent Medical Srl with Fiscal Code 37799854 recorded a turnover of 2024 of 20.776, with a net profit of -2.038 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata nespecializat having the NACE code 4690.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Bioinvent Medical Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 1.668 28.876 14.108 18.197 41.178 45.703 25.996 20.776
Total Income - EUR - - 1.673 28.947 14.228 18.406 41.275 45.686 26.094 20.792
Total Expenses - EUR - - 1.632 22.344 12.481 11.625 27.967 42.007 28.200 22.622
Gross Profit/Loss - EUR - - 41 6.603 1.747 6.781 13.308 3.679 -2.105 -1.830
Net Profit/Loss - EUR - - -9 5.735 1.324 6.337 12.482 3.252 -2.329 -2.038
Employees - - 0 0 0 0 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -19.6%, from 25.996 euro in the year 2023, to 20.776 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Bioinvent Medical Srl

Rating financiar

Financial Rating -
BIOINVENT MEDICAL SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Bioinvent Medical Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Bioinvent Medical Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Bioinvent Medical Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Bioinvent Medical Srl - CUI 37799854

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 32 0 0 0 0 12 0 55
Current Assets - - 628 7.197 7.542 14.597 22.351 19.229 19.190 17.533
Inventories - - 0 1.946 5.448 9.577 12.614 11.882 8.572 8.040
Receivables - - 0 223 1.050 842 1.408 640 3.091 2.973
Cash - - 628 5.027 1.044 4.178 8.329 6.706 7.527 6.519
Shareholders Funds - - 35 5.769 6.981 13.186 19.885 17.222 14.841 12.720
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 626 1.428 561 1.411 2.466 2.019 4.349 4.867
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4690 - 4690"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 17.533 euro in 2024 which includes Inventories of 8.040 euro, Receivables of 2.973 euro and cash availability of 6.519 euro.
The company's Equity was valued at 12.720 euro, while total Liabilities amounted to 4.867 euro. Equity decreased by -2.038 euro, from 14.841 euro in 2023, to 12.720 in 2024.

Risk Reports Prices

Reviews - Bioinvent Medical Srl

Comments - Bioinvent Medical Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.